| pubmed-article:9240634 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:9240634 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
| pubmed-article:9240634 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9240634 | pubmed:dateCreated | 1997-8-7 | lld:pubmed |
| pubmed-article:9240634 | pubmed:abstractText | To define the maximum tolerated dose (MTD) by describing the dose-limiting toxicity (DLT) of weekly paclitaxel (PAC) given as a 1-h I.V. infusion in patients with head and neck cancer concomitant to irradiation. | lld:pubmed |
| pubmed-article:9240634 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9240634 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9240634 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9240634 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9240634 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9240634 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9240634 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9240634 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9240634 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:HoffmannWW | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:SchmidbergerH... | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:BambergMM | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:HessC FCF | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:BudachWW | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:BelkaCC | lld:pubmed |
| pubmed-article:9240634 | pubmed:author | pubmed-author:BochtlerHH | lld:pubmed |
| pubmed-article:9240634 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9240634 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9240634 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:9240634 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9240634 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9240634 | pubmed:pagination | 691-6 | lld:pubmed |
| pubmed-article:9240634 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:meshHeading | pubmed-meshheading:9240634-... | lld:pubmed |
| pubmed-article:9240634 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9240634 | pubmed:articleTitle | Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial. | lld:pubmed |
| pubmed-article:9240634 | pubmed:affiliation | Department of Radiotherapy, University of Tubingen, Germany. | lld:pubmed |
| pubmed-article:9240634 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9240634 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9240634 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
